EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
Clinical trials for EXOCRINE PANCREATIC INSUFFICIENCY (EPI) explained in plain language.
Never miss a new study
Get alerted when new EXOCRINE PANCREATIC INSUFFICIENCY (EPI) trials appear
Sign up with your email to follow new studies for EXOCRINE PANCREATIC INSUFFICIENCY (EPI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New enzyme pill could ease digestion for cystic fibrosis patients
Disease control Recruiting nowThis study tests a new medicine called ANG003 for people with cystic fibrosis who have trouble digesting food because their pancreas doesn't work properly. The medicine is a type of enzyme replacement therapy, similar to the standard treatment Creon. The goal is to see if ANG003 …
Matched conditions: EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
Phase: PHASE2 • Sponsor: Anagram Therapeutics, Inc. • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New study aims to uncover hidden diabetes type in patients
Knowledge-focused Recruiting nowThis observational study will examine how the pancreas works in 310 adults with type 2 diabetes. Researchers want to see if some patients actually have a different form of diabetes called pancreatogenic diabetes. Participants will give blood and stool samples, have a pancreas ult…
Matched conditions: EXOCRINE PANCREATIC INSUFFICIENCY (EPI)
Sponsor: West Kazakhstan Marat Ospanov Medical University • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC